Published 2019 | Version v1
Publication

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study

Additional details

Created:
March 27, 2023
Modified:
November 28, 2023